CNCEC(601117)
Search documents
中国化学:中国化学关于董事、总经理工作调整的公告
2024-09-26 10:02
证券代码:601117 股票简称:中国化学 公告编号:临 2024-051 二○二四年九月二十七日 中国化学工程股份有限公司 关于董事、总经理工作调整的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 担个别及连带责任。 中国化学工程股份有限公司(以下简称"公司")董事会于 近日收到董事、总经理文岗先生的书面辞职报告,因工作调整原 因,文岗先生申请辞去公司董事、总经理职务。辞职后,文岗先 生将不再担任公司任何职务。根据《公司法》和《公司章程》等 有关规定,文岗先生的辞职未导致公司董事会成员低于法定最低 人数,不会影响公司董事会正常运作,文岗先生的书面辞职报告 自送达公司董事会时生效。 文岗先生在公司任职期间,恪尽职守、开拓创新、担当作为, 为公司经营管理、规范运作、高质量发展发挥了重要作用,公司 及公司董事会对文岗先生为本公司所作出的突出贡献表示衷心 感谢! 特此公告。 中国化学工程股份有限公司 ...
中国化学:中国化学2024年第二次临时股东大会法律意见书
2024-09-20 10:15
北京海润天睿律师事务所 关于中国化学工程股份有限公司 2024 年第二次临时股东大会的法律意见书 致:中国化学工程股份有限公司 北京海润天睿律师事务所(以下简称"本所")接受中国化学工程股份有限 公司(以下简称"公司")的委托,指派王彩虹律师、马佳敏律师出席公司 2024 年第二次临时股东大会,并依据《中华人民共和国公司法》(以下简称"《公司 法》")、《上市公司股东大会规则》(以下简称"《股东大会规则》")等相 关法律、法规、规范性文件及《中国化学工程股份有限公司章程》(以下简称"《公 司章程》")的规定,就公司本次股东大会的召集、召开程序、出席会议人员的 资格、召集人资格、表决程序、表决结果等有关事宜出具本法律意见书。 一、本次股东大会的召集、召开程序 (一)经本所律师审查,公司关于召开本次股东大会的通知已于 2024 年 8 月 31 日在中国证监会指定的信息披露媒体上公告。 本次股东大会现场会议于 2024 年 9 月 20 日 14:30 在北京市东城区东直门 内大街 2 号中国化学大厦如期召开,会议由公司董事长莫鼎革先生主持。 (二)本次股东大会采用现场投票与网络投票相结合的方式,公司通过上海 证 ...
中国化学:中国化学2024年第二次临时股东大会决议公告
2024-09-20 10:12
证券代码:601117 证券简称:中国化学 公告编号:2024-050 中国化学工程股份有限公司 2024 年第二次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 (一)股东大会召开的时间:2024 年 9 月 20 日 (二)股东大会召开的地点:中国化学大厦 (三)出席会议的普通股股东和恢复表决权的优先股股东及 其持有股份情况: | 1、出席会议的股东和代理人人数 | 818 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 3,029,556,816 | | 3、出席会议的股东所持有表决权股份数占公司有表 决权股份总数的比例(%) | 49.5911 | (四)表决方式是否符合《公司法》及《公司章程》的规定, 大会主持情况等。 2、公司在任监事 3 人,出席 3 人; 3、董事会秘书朱今风先生出席本次股东大会;部分高管列 席本次股东大会。 二、 议案审议情况 (一) 非累积投票议案 1、议案名 ...
中国化学:中国化学关于经营情况简报的公告
2024-09-18 08:58
证券代码:601117 股票简称:中国化学 公告编号:临 2024-049 中国化学工程股份有限公司 关于经营情况简报的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 担个别及连带责任。 现将公司 2024 年 1-8 月主要经营情况公布如下,供各位投 资者参阅。 一、 按业务类型统计 1 业务类型 数量 合同金额 建筑工程承包 2154 2448.24 其 中 化学工程 1724 1923.94 基础设施 350 431.58 环境治理 80 92.72 勘察设计监理咨询 1393 27.84 实业及新材料销售 49.57 现代服务业 7.48 其他 28.15 合计 3547 2561.28 单位:亿元 币种:人民币 二、 按地区分布统计 单位:亿元 币种:人民币 | 地区 | 合同金额 | | --- | --- | | 境内 | 1934.41 | | 境外 | 626.87 | | 合计 | 2561.28 | 三、 重大合同列示 | 序 号 | 单位名称 | 项目合同名称 | 合同金额 | | --- | --- | - ...
中国化学:中国化学2024年第二次临时股东大会会议资料
2024-09-13 09:23
中国化学工程股份有限公司 2024年第二次临时股东大会 会议资料 网络投票系统:上海证券交易所股东大会网络投票系统。 网络投票起止时间:自 2024 年 9 月 20 日至 2024 年 9 月 20 日。 采用上交所网络投票系统(http://vote.sseinfo.com/h ome),通过交易系统投票平台的投票时间为股东大会召开当 日的交易时间段,即 9:15-9:25,9:30-11:30,13:00-15:00; 通过互联网投票平台的投票时间为股东大会召开当日的 9:15 -15:00。 二○二四年九月 中国化学工程股份有限公司 2024 年第二次临时股东大会会议议程 一、会议议程 时间:2024 年 9 月 20 日(星期五)14:30 地点:北京市东城区东直门内大街 2 号 中国化学大厦 | 时 间 | 议 程 | | --- | --- | | 14:00-14:20 | 股东登记,会议签到 | | 14:30-16:00 | 一、宣布会议开始,介绍参会人员情况 | | | 二、汇报、审议议案 | | | 三、推选监票人 | | | 四、投票表决 | | | 五、计票、监票 | | | 六、 ...
中国化学:Q2业绩放缓,实业收入、毛利率提升
Haitong Securities· 2024-09-10 00:08
Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company reported a revenue of 91.037 billion yuan for H1 2024, a year-on-year decrease of 0.34%, while the net profit attributable to the parent company was 2.839 billion yuan, down 3.63%. However, the net profit excluding non-recurring items increased by 3.46% to 3.050 billion yuan [3] - The company experienced a decline in revenue and net profit in Q2 2024, with Q1 showing a revenue increase of 5.54% and Q2 a decrease of 5.53%. The net profit for Q1 increased by 9.50%, while Q2 saw a decrease of 11.58% [3] - The company’s gross margin improved by 1.06 percentage points to 9.39% in H1 2024, with specific segments like chemical engineering and new materials showing significant improvements [3] - The company signed new contracts worth 215.418 billion yuan from January to July 2024, a year-on-year increase of 10.02%, with overseas contracts increasing by 153.93% [3] - The earnings per share (EPS) for 2024 and 2025 are projected to be 0.97 yuan and 1.06 yuan, respectively, with a reasonable valuation range of 9.68 to 10.65 yuan based on a price-to-earnings ratio of 10-11 times for 2024 [3] Financial Summary - For H1 2024, the company’s revenue by segment was as follows: chemical engineering 73.918 billion yuan, infrastructure 10.124 billion yuan, environmental governance 1.124 billion yuan, industrial and new materials 4.442 billion yuan, and modern services 0.747 billion yuan [3] - The company’s operating cash flow turned into a net outflow of 4.571 billion yuan in H1 2024, compared to a net inflow of 226 million yuan in H1 2023 [3] - The company’s total revenue is projected to grow from 179.196 billion yuan in 2023 to 194.126 billion yuan in 2024, with a year-on-year growth rate of 8.3% [4][10]
中国化学:现金流承压,实业项目稳步推进
申万宏源· 2024-09-05 06:09
Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company's net profit for H1 2024 decreased by 3.63% year-on-year, slightly below expectations, with total revenue of 91 billion, a decrease of 0.34% year-on-year [6] - The chemical engineering segment showed stable growth, while infrastructure engineering experienced a slowdown [6] - The company is actively pursuing industrial projects to create a second growth curve, focusing on high-value products in the new materials sector [6] - Profit forecasts for 2024-2026 have been revised downwards, but the company is expected to gradually contribute profits from ongoing industrial projects [6] Financial Summary - As of June 30, 2024, the company's total revenue is projected to be 188.335 billion, with a year-on-year growth rate of 5.1% [7] - The net profit for 2024 is estimated at 5.789 billion, reflecting a year-on-year growth of 6.7% [7] - The company's gross margin is expected to remain stable at around 9.2% for the next few years [7][8] - The company's total assets and liabilities ratio stands at 69.83% [3] Segment Performance - The chemical engineering segment generated revenue of 739 billion in H1 2024, with a gross margin of 9.89% [6] - The infrastructure segment's revenue decreased by 20.23% year-on-year, with a gross margin of 5.80% [6] - The new materials segment achieved revenue of 44.4 billion, with a gross margin of 9.60%, reflecting a year-on-year growth of 6.63% [6]
中国化学:化学工程稳中有升,海外新签合同高增长
中国银河· 2024-09-04 10:00
Investment Rating - The report maintains a "Recommended" rating for the company [4]. Core Views - The company reported a slight decline in revenue and net profit for the first half of 2024, with revenue at 910.37 billion yuan, down 0.34% year-on-year, and net profit at 28.39 billion yuan, down 3.63% year-on-year [1]. - The company experienced growth in its chemical engineering and new materials segments, with overseas performance showing significant improvement, particularly in new contract signings [1][2]. - The company is actively participating in the "Belt and Road" initiative, leading to substantial growth in overseas contracts, which increased by 132.53% year-on-year [1]. Financial Performance Summary - Revenue breakdown for H1 2024: Chemical engineering revenue was 739.18 billion yuan (up 4.32% YoY), infrastructure revenue was 101.24 billion yuan (down 20.23% YoY), environmental governance revenue was 11.24 billion yuan (down 22.39% YoY), and industrial and new materials revenue was 44.42 billion yuan (up 6.63% YoY) [1]. - The company achieved a gross margin of 9.39%, an increase of 1.05 percentage points year-on-year, while the net margin was 3.44%, a slight decrease of 0.07 percentage points [1]. - The company’s asset-liability ratio decreased to 69.83%, down 1.39 percentage points year-on-year, indicating improved financial stability [1]. Future Profitability Forecast - The company is projected to achieve net profits of 56.72 billion yuan, 61.86 billion yuan, and 68.25 billion yuan for the years 2024, 2025, and 2026, respectively, reflecting growth rates of 4.53%, 9.06%, and 10.33% [2][3]. - Corresponding P/E ratios are expected to be 7.04, 6.46, and 5.85 for the same years [2].
中国化学:2024年中报点评:化工主业及实业业务稳健增长,境外业务量利齐升
EBSCN· 2024-09-03 02:39
Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company reported a slight decline in revenue and net profit for the first half of 2024, with revenue at 91 billion CNY, a year-on-year decrease of 0.3%, and net profit at 28 billion CNY, down 3.6% [2][3] - The company has a strong order backlog, with new contracts signed in H1 2024 amounting to 203.57 billion CNY, representing a year-on-year increase of 10.1% [3] - The company's overseas business has shown significant growth, with new contracts signed increasing by 132.5% year-on-year [3] Summary by Sections Financial Performance - In H1 2024, the company achieved revenue of 91 billion CNY, with a net profit of 28 billion CNY and a non-recurring net profit of 31 billion CNY [2] - The second quarter of 2024 saw revenue of 45.9 billion CNY, a decrease of 5.5% year-on-year, and a net profit of 16 billion CNY, down 11.6% [2] - The gross profit margin improved to 9.4%, with a net profit margin of 3.4% [4] Business Segments - The chemical engineering, infrastructure, and environmental governance sectors reported revenues of 73.9 billion CNY, 10.1 billion CNY, and 1.1 billion CNY respectively, with year-on-year growth rates of 4.3%, -20.2%, and -22.4% [3] - The company’s domestic and overseas revenue was 69.7 billion CNY and 20.7 billion CNY, reflecting a year-on-year change of -3.2% and +10.0% respectively [3] Profitability and Cash Flow - The company’s financial expenses increased significantly due to exchange losses, leading to a rise in the financial expense ratio [4] - Operating cash flow was negative at -4.57 billion CNY, with a significant outflow compared to the previous year [4] Future Outlook - The profit forecasts for 2024-2026 have been adjusted downwards to 5.45 billion CNY, 5.97 billion CNY, and 6.63 billion CNY, reflecting a decrease of 7.4% for 2024 [4] - The strong growth in new contracts and overseas business is expected to drive stable growth in the company's performance [4]
中国化学:境外收入新签增长强劲,毛利率改善
Guolian Securities· 2024-09-02 13:30
Investment Rating - The investment rating for the company is "Buy" (maintained) [6] Core Views - The company has shown strong growth in new overseas contracts, with a notable increase in gross profit margins. The chemical engineering segment continues to grow steadily, reflecting a solid order backlog and good project execution pace. The company's "two business" strategic transformation is progressing well, supported by steady growth in its industrial and new materials businesses [3][9][10]. Summary by Sections Financial Performance - In H1 2024, the company's total revenue was 91 billion yuan, a slight year-on-year decrease. The net profit attributable to shareholders was 2.8 billion yuan, down 4% year-on-year, while the net profit excluding non-recurring items was 3.1 billion yuan, up 3% year-on-year. In Q2 2024, total revenue was 45.9 billion yuan, down 6% year-on-year, with a net profit of 1.6 billion yuan, down 12% year-on-year [9]. - The company’s revenue from various segments in H1 2024 was as follows: chemical engineering 73.9 billion yuan (up 4% YoY), infrastructure 10.1 billion yuan (down 20% YoY), environmental governance 1.1 billion yuan (down 22% YoY), industrial and new materials 4.4 billion yuan (up 7% YoY), and modern services 0.7 billion yuan (down 53% YoY) [9]. - The gross profit margin improved slightly to 9.8%, up 1.1 percentage points year-on-year, with the Q2 gross profit margin at 11.1%, up 2.0 percentage points year-on-year [9][10]. Strategic Outlook - The company expects revenue growth of 13% annually from 2024 to 2026, with projected revenues of 201.6 billion yuan in 2024, 228.2 billion yuan in 2025, and 258.6 billion yuan in 2026. The net profit attributable to shareholders is expected to reach 6.1 billion yuan in 2024, 7.1 billion yuan in 2025, and 8.1 billion yuan in 2026, reflecting a compound annual growth rate (CAGR) of 15% over three years [9][10]. - The company is projected to maintain a price-to-earnings (P/E) ratio of 10 times for 2024, supporting the "Buy" rating [10].